K2M Inc.
This article was originally published in Start Up
Executive Summary
K2M has implemented eight silos of research in spine, each essentially acting as its own independent technology incubator, dedicated to developing spine medical technologies for specific indications.
You may also be interested in...
Welsh Carson Sits in K2M Driver's Seat
With the backing of the private equity powerhouse Welsh Carson, K2M will look to grow beyond its historical niche in complex spinal cases, though it will have to do so without any financial ties to the surgeons who once owned part of the company.
Welsh Carson Sits in K2M Driver's Seat
With the backing of the private equity powerhouse Welsh Carson, K2M will look to grow beyond its historical niche in complex spinal cases, though it will have to do so without any financial ties to the surgeons who once owned part of the company.
Preserving Spinal Motion, Preserving Options
Dynamic stabilization may sound like an oxymoron, but the concept is driving compound annual growth of more than 50% over the next decade in a new segment of the spine industry. The US market for spinal motion preserving and nonfusion products was worth approximately $186 million in 2004, and is projected to reach more than $1.5 billion in the year 2009, according to "US Markets for Spinal Motion Preserving Devices," a report just published by Windhover/Medtech Insight.